Deals & Cases

BOYANOV & Co. advised Novartis on transactions with GSK


BOYANOV & Co. advised Novartis on transactions with GSK including: acquisition of GSK oncology portfolio by Novartis and transfer of the non-influenza vaccines business to GSK. The team advised Novartis on the Bulgarian legal implications of the global process (including regulatory, labour, PD protection, etc.). BOYANOV & Co.’s team on the deal was led by Mr. Yordan Naydenov, Partner and Head of Corporate and M&A.